Articles On Integral Diagnostics (ASX:IDX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Guess which ASX All Ords stock just rocketed 28% on a new commercial contract!
The All Ordinaries Index (ASX: XAO) is up 0.3% today, with plenty of help from one rocketing ASX All Ords stock. The fast-gaining company in question is 4DMedical Ltd (ASX: 4DX). Shares in the respiratory imaging technology company closed... |
Motley Fool | IDX | 11 months ago |
|
Tuesday’s HotCopper Trends: Kalgoorlie discovery, Tivan JV update | April 15, 2025
The ASX has been up 0.25% higher at 7,767 points. Kalgoorlie Gold Mining (ASX:KAL) has been among the most watched stock on HotCopper forums on discovery of primary gold mineralisation beneath the near-surface supergene gold blanket at i... |
themarketonline.com.au | IDX | 11 months ago |
|
Exploring Undervalued Stocks on the ASX
Highlights: Australian shares experience market fluctuations, leading to discussions about undervalued stocks. Companies with significant discounts based on estimated fair values are being examined. Various sectors, includin... |
Kalkine Media | IDX | 11 months ago |
|
Health Check: LTR Pharma finds fast-track path to US erectile dysfunction market
It’s up and go time for LTR in the US market All the budget healthcare news – and it’s a short item Prescient launches phase 2a study for a rare blood cancer The developer of a nasal spray-mist erectile dysfunction (ED) treatment, LTR P... |
Stockhead | IDX | 11 months ago |
|
ASX Stocks in Focus Amid Market Adjustments
Highlights: Several ASX-listed stocks have experienced declines, attracting attention for their market positions and operational outlooks. Companies in education, healthcare, and intellectual property services have shown developm... |
Kalkine Media | IDX | 1 year ago |
|
ASX Stocks in Focus Following Recent Market Downturn
Highlights: Several ASX-listed companies have experienced a decline in share value, presenting key insights into their financial performance. Macquarie's latest report outlines businesses expected to see operational improvements... |
Kalkine Media | IDX | 1 year ago |
|
Top broker bullish on these beaten down ASX shares
2025 has proven difficult for several beaten-down ASX shares. After the broad market selloff in February, much of the market has yet to recover in full. But this has opened the funding window to own passive interests in high-quality Aus... |
Motley Fool | IDX | 1 year ago |
|
Is it time to jump back into the ASX stock market?
Highlights: The S&P/ASX 200 Index has experienced a notable decline since mid-February 2025. Chris Stott of 1851 Capital has identified specific companies he believes have strong prospects. The current market environment presents... |
Kalkine Media | IDX | 1 year ago |
|
Rudi’s Comprehensive February 2025 Review
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck A compilation of stories relating to the February 2025 corporate repo... |
FNArena | IDX | 1 year ago |
|
ESG Focus: Fund Flows, Tariffs, Defence & AI
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena’s dedicated ESG Focus news section zooms in on matters Environmental, Social... |
FNArena | IDX | 1 year ago |
|
Is it time to jump back into the ASX stock market? This fund manager thinks so
The ASX stock market has gone through one of the largest dips since the COVID crash. The S&P/ASX 200 Index (ASX: XJO) is down 8.5% since 14 February 2025. While market declines can be worrying, brave investors may find that some busines... |
Motley Fool | IDX | 1 year ago |
|
2 ASX small-cap shares to buy with big potential
ASX small-cap shares can be exciting ideas if they have good growth potential. Businesses with smaller market capitalisations aren't followed by as many fund managers or brokers, so there's a higher chance they're undervalued by the mar... |
Motley Fool | IDX | 1 year ago |
|
The Overnight Report: Trump Slump Deepens
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7895.00 – 70.00 – 0.88% S&P ASX 200 7962.30... |
FNArena | IDX | 1 year ago |
|
The Monday Report – 10 March 2025
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a positive session might lay ahead for the Australian sha... |
FNArena | IDX | 1 year ago |
|
Insider Moves Spotlight Three Undervalued Small Cap Stocks in the Global Market
Highlights: Market shifts present scenarios where select small-cap stocks show pricing differences relative to their fundamentals. Business sectors such as healthcare, mining, and energy continue to exhibit operational developmen... |
Kalkine Media | IDX | 1 year ago |
|
The Overnight Report: (Another) Sour Friday
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US President Donald Trump said Thursday that he would allow Mexico and Canada to avo... |
FNArena | IDX | 1 year ago |
|
Rudi’s View: To Sell Or Not To Sell
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, EditorWithin the space of a number of weeks... |
FNArena | IDX | 1 year ago |
|
Health Check: More healthcare ‘reverse ferrets’ from Trump’s razor gang
A key FDA quality control lab will remain open, while a judge halts DOGE’s plans to cull billions of research grants Cochlear and Resmed win an upgrade after their post-results share thumping Dissident holder sells out after Percheron CEO... |
Stockhead | IDX | 1 year ago |
|
ASX February health winners: Sector falls almost 8pc in weaker month for markets
The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA Pacific Edge was... |
Stockhead | IDX | 1 year ago |
|
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner Some healthcare analysts be... |
Stockhead | IDX | 1 year ago |
|
FNArena Corporate Results Monitor – 27-02-2025
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Met... |
FNArena | IDX | 1 year ago |
|
“Your Stock Request” – 27 February 2025
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | IDX | 1 year ago |
|
This ASX healthcare stock is crashing 30% on half year results
The Integral Diagnostics Ltd (ASX: IDX) share price is having a day to forget on Wednesday. In morning trade, the ASX healthcare stock is down 30% to $2.00. This follows the release of the medical imaging services provider's half year resul... |
Motley Fool | IDX | 1 year ago |
|
The Overnight Report: Anxiety Rising
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting another cautious, slightly weaker opening for the ASX tod... |
FNArena | IDX | 1 year ago |
|
3 ASX small-cap shares with a 'solid growth outlook' for 2025
Looking to buy a few ASX small-cap shares to potentially help turbocharge your portfolio returns in 2025? Then Lucas Goode, a portfolio manager for the IML Australian Smaller Companies Fund, has three companies you may wish to run your slid... |
Motley Fool | IDX | 1 year ago |
|
Undervalued Small-Cap Stocks with Insider Activity on the ASX for January 2025
Headlines ASX200 hits a new peak amid positive market sentiment. Insider actions offer insights into small-cap opportunities. Spotlight on Healius, Integral Diagnostics, and K&S Corporation. Promising Australian Small-Caps in... |
Kalkine Media | IDX | 1 year ago |
|
Rudi’s View: Cochlear, Guzman y Gomez, SiteMinder, Wesfarmers & Xero
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor Morningstar's selection of Best Buys... |
FNArena | IDX | 1 year ago |
|
Rudi’s View: All-Weather Portfolio In 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor As is custom this time of the year, f... |
FNArena | IDX | 1 year ago |
|
ASX December health sector winners… and a 91pc drop for a trial-flopped stock
The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece... |
Stockhead | IDX | 1 year ago |
|
6 ASX All Ords shares lifted to 'strong buy' consensus ratings for the new year
S&P/ASX All Ords (ASX: XAO) shares fell 3.2% in December in an unusually weak final month of the year. Meantime, some brokers changed their ratings on various ASX stocks before heading off on holidays. Here are six ASX All Ords sh... |
Motley Fool | IDX | 1 year ago |
|
Ask FNArena: What To Buy (Pre & Post Correction)
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Earlier this month we asked investors to send in their questions. Tod... |
FNArena | IDX | 1 year ago |
|
Small caps poised to shine as ‘valuation disconnect’ exposed
A “valuation disconnect” between groups of larger stocks on the ASX versus their smaller counterparts will throw up plenty of value opportunities in 2025, helped by an overdue pullback in global sharemarkets. That’s the view of the small an... |
Stockhead | IDX | 1 year ago |
|
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Today's update includes: -A Conflict In Waiting?-Banks And Super Fund... |
FNArena | IDX | 1 year ago |
|
Diagnostic Imaging Radiates Opportunity
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel Pending MRI deregulation is behind the now approved merger of Integral Diagnosti... |
FNArena | IDX | 1 year ago |
|
Australian Broker Call *Extra* Edition – Dec 16, 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha... |
FNArena | IDX | 1 year ago |
|
The Overnight Report: Oil, Gold & US CPI
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US Equities had a weak session, but nothing like the growth stocks sell-off that occ... |
FNArena | IDX | 1 year ago |
|
Integral Diagnostics clears ACCC hurdle for Capitol Health takeover
Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (AS... |
ShareCafe | IDX | 1 year ago |
|
Here's the latest broker upgrades on ASX All Ords shares
The latest round of broker upgrades on ASX All Ords shares are here and you may as well strap in because there's a few names to discuss. Brokers are bullish on companies ranging from the healthcare sector, to energy, to food, giving inv... |
Motley Fool | IDX | 1 year ago |
|
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns
The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX Paradigm Biopharmaceuticals rose 151% in Novembe... |
Stockhead | IDX | 1 year ago |
|
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th... |
Stockhead | IDX | 1 year ago |
|
3 small-cap ASX healthcare shares 'with strong prospects'
ASX healthcare shares finished in the red on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) falling 1.11% while the S&P/ASX 200 Index (ASX: XJO) also tumbled 0.5%. In a recent note, fund manager IML identified th... |
Motley Fool | IDX | 1 year ago |
|
The Overnight Report: Risk Off Friday
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8118.00 – 52.00 – 0.64% S&P ASX 200 8160.00... |
FNArena | IDX | 1 year ago |
|
Broker Upgrades: Whole is greater than the sum, as Jarden urges buying into IDX-CAJ merger
Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential The imaging sector is by no means the sexiest part... |
Stockhead | IDX | 1 year ago |
|
Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Aidoc’s AI technology enhances radiology services at IDX, significantly improving... |
FNArena | IDX | 1 year ago |
|
Wall St posts minor gains amid Middle East tensions
The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent... |
ShareCafe | IDX | 1 year ago |
|
Wall St posts minor gains amid Middle East tensions
The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent t... |
ShareCafe | IDX | 1 year ago |
|
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Healthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as Fed cuts rates How ASX biotechs performed in the month of September The S&P 500 Health Care Index, a key world benchmark for health... |
Stockhead | IDX | 1 year ago |
|
Australian Broker Call *Extra* Edition – Sep 26, 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha... |
FNArena | IDX | 1 year ago |
|
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment The ASX Healthcare Index (AS... |
Stockhead | IDX | 1 year ago |
|
Dow breaks record amid tech turmoil
The Dow Jones Industrial Average climbed to a record high overnight, as Wall Street attempted to recover from a steep sell-off earlier this month. The 30-stock index gained 243.63 points, or 0.59 per cent, closing at a new record of 41,335.... |
ShareCafe | IDX | 1 year ago |